Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S announced an update on its share repurchase program. The company initiated a program on May 6, 2026, as part of a larger plan to repurchase up to DKK 15 billion in shares over a 12-month period starting February 4, 2026. Under the May 6 program, Novo Nordisk will repurchase B shares up to DKK 11,200,000,010.45 between May 6, 2026, and February 1, 2027. Between August 4 and August 7, 2026, the company repurchased 200,000 to 215,000 B shares daily, with average prices ranging from DKK 294.26 to DKK 308.29. As of August 7, 2026, the total accumulated repurchases under the program reached 13,125,000 B shares, amounting to DKK 3,980,067,920. The company also reported transactions related to incentive programs, resulting in a net transfer of 3,144,604 shares. Novo Nordisk currently holds 41,924,876 B shares as treasury shares, representing 0.9% of the total share capital. Since February 4, 2026, the company has repurchased a total of 27,884,179 B shares at an average price of DKK 279.01, totaling DKK 7,780,067,909.